CAB LA Archives - Crowd 360Crowd 360

Topic: CAB LA

July 25, 2017

Long-Acting Injectable Cabotegravir for PrEP Well Tolerated in HPTN 077: Results Support Dosing Regimens in HPTN 083 and HPTN 084

Tags: AIDS, CAB LA, Cabotegravir, HIV, HIV Prevention Trials Network, HPTN, HPTN 077, IAS, IAS 2017, International AIDS Society, long-acting injectable cabotegravir, Pre-exposure prophylaxis, PrEP